Martin C. Dyroff
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 7
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
- Estrogen and related hormone effects 4
- Chemical Health and Safety top 10%
-
- Chronic Myeloid Leukemia Treatments 7
-
- DNA Repair Mechanisms 4
-
- Immunodeficiency and Autoimmune Disorders 4
-
- Eicosanoids and Hypertension Pharmacology 2
- Co-authors
- Paul V. PlourdeMichael DukesJames A. SwenbergFrank C. RichardsonRobert A. NealJames A. PoppScott GrimmJoyce A. Boucheron
- Cited by
- Cancer ResearchPharmacologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Blood (1 paper)Environmental Health Perspectives (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Martin C. Dyroff
28 papers receiving 964 citations
Peers
Comparison fields: 5 of 99
- Cancer Research 323
- Pharmacology 153
- Genetics 278
- Chemical Health and Safety 6
- Health, Toxicology and Mutagenesis 105
Countries citing papers authored by Martin C. Dyroff
This map shows the geographic impact of Martin C. Dyroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin C. Dyroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin C. Dyroff more than expected).
Fields of papers citing papers by Martin C. Dyroff
This network shows the impact of papers produced by Martin C. Dyroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin C. Dyroff. The network helps show where Martin C. Dyroff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin C. Dyroff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 15 | |
| 6 | 2017 | 3 | |
| 7 | 2008 | 1 | |
| 8 | 2003 | 14 | |
| 9 | 1997 | 17 | |
| 10 | 1997 | 7 | |
| 11 | Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. | 1997 | 59 |
| 12 | 1995 | 100 | |
| 13 | 1994 | 204 | |
| 14 | 1994 | 14 | |
| 15 | 1986 | 39 | |
| 16 | 1985 | 71 | |
| 17 | 1984 | 124 | |
| 18 | 1984 | 13 | |
| 19 | Dose response for DNA alkylation, [3H]thymidine uptake into DNA, and O6-methylguanine-DNA methyltransferase activity in hepatocytes of rats and mice continuously exposed to dimethylnitrosamine. | 1984 | 27 |
| 20 | 1983 | 41 |
About Martin C. Dyroff
Martin C. Dyroff is a scholar working on Genetics, Hematology and Pharmacology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Carcinogens and Genotoxicity Assessment (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), DNA Repair Mechanisms (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Estrogen and related hormone effects (4 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Cancer Research (323 citations), Pharmacology (153 citations) and Genetics (278 citations). Martin C. Dyroff has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Paul V. Plourde, Michael Dukes, James A. Swenberg, Frank C. Richardson, Robert A. Neal, James A. Popp, Scott Grimm, Joyce A. Boucheron, Allison Joyce and Nam‐ho Huh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.